Bratman_Lab_Biobank, Canada

Certification Status: Certification Form

Registration Status: Completed

Objective: The objective of this in-laboratory Biobank is to track and store clinical blood samples and their derivatives, frozen blocks/slides for the research projects run by the Bratman lab and its collaborators when needed. These research projects are focused on blood-based cancer detection and monitoring.

Registered Biobank Name	Bratman_Lab_Biobank
Biobank Leader	Zhen Zhao
Country	Canada
Email for biobank inquiries	zhen.zhao@uhnresearch.ca
Principal Investigator	Scott V Bratman
Website
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Oligo - Collection aimed at supporting several research projects, a research group or a research consortium

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).